GKB Ophthalmics credit ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	FY23Mar 2023

	11.2
	10.8
	0.41×
	0.39×
	−10.24×
	−9.86×
	−2.43×
	29.0%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

GKB₹60.01

GKB Ophthalmics Limited

· Pharma & Health

₹ CrorePeersFABTECH LAXMIDENTL TARSONS FISCHERMcap ₹30.2 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

	Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023
	Total Debt	11.2
	Net Debt	10.8
	Total Debt/Equity	0.41
	Net Debt/Equity	0.39
	Total Debt/EBITDA	-10.24
	Net Debt/EBITDA	-9.86
	Interest Coverage (EBIT/Interest)	-2.43
	Total Debt/Total Capital %	28.96

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY23 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.